AnalystsKemp DolliverKemp Dolliver's Stock Forecasts
AnalystsKemp Dolliver
Analyst Ranking
Bottom 15%
#3914 out of 4565 analysts
Average Return
-13.26%
Win Rate
22%2 out of 9
Risk vs Reward
Poor
Good
Kemp Dolliver Analyst Color
Get additional color on Kemp Dolliver's coverage of popular stocks
Kemp Dolliver's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Outlook Therapeutics IncOTLK | 1 | Strong Buy | $31.40 | +283.39% | Upgrades | 3 months ago |
Point Biopharma Global IncPNT | 1 | Hold | $12.50 | 0.00% | Downgrades | 4 months ago |
Oncternal Therapeutics IncONCT | 1 | Strong Buy | $40.00 | +384.85% | Upgrades | 5 months ago |
Lantheus Holdings IncLNTH | 1 | Strong Buy | $100.00 | +53.37% | Initiates Coverage On | 5 months ago |
Eyenovia IncEYEN | 1 | Strong Buy | $8.00 | +1,025.18% | Initiates Coverage On | 6 months ago |
Procaps Group SaPROC | 1 | Hold | $4.50 | +65.02% | Downgrades | 8 months ago |
Genelux CorpGNLX | 1 | Hold | $25.00 | +653.01% | Initiates Coverage On | a year ago |
Electrocore IncECOR | 1 | Strong Buy | $18.75 | N/A | Initiates Coverage On | a year ago |
Edesa Biotech IncEDSA | 1 | Strong Buy | $13.00 | N/A | Maintains | a year ago |
Scynexis IncSCYX | 1 | Strong Buy | $8.00 | N/A | Assumes | 2 years ago |
Verrica Pharmaceuticals IncVRCA | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Icecure Medical LtdICCM | 1 | Strong Buy | $5.65 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.